Sufentanil Citrate Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Sufentanil Citrate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on May 3, 2022. Reported reason: Other

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-3382-21
Dosage Form
Injection
Presentation
Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21)
Initial Posting
May 3, 2022

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.